Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2009 1
2012 1
2013 2
2014 3
2015 2
2016 3
2017 1
2019 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Intrauterine device and pelvic inflammatory disease.
Khomassuridze AG, Tsertsvadze GL, Tsereteli TG. Khomassuridze AG, et al. Among authors: tsereteli tg. Adv Contracept. 1997 Mar;13(1):71-8. doi: 10.1023/a:1006572529894. Adv Contracept. 1997. PMID: 9181187 Clinical Trial.
The introduction of first trimester medical abortion in Armenia.
Louie KS, Chong E, Tsereteli T, Avagyan G, Vardanyan S, Winikoff B. Louie KS, et al. Among authors: tsereteli t. Reprod Health Matters. 2015 Feb;22(44 Suppl 1):56-66. doi: 10.1016/S0968-8080(15)43824-8. Reprod Health Matters. 2015. PMID: 25702069
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S, Tsereteli T, Kamilov A, Kurbanbekova D, Yusupov D, Kasimova F, Jymagylova D, Winikoff B. Raghavan S, et al. Among authors: tsereteli t. Eur J Contracept Reprod Health Care. 2013 Apr;18(2):104-11. doi: 10.3109/13625187.2013.763225. Epub 2013 Feb 7. Eur J Contracept Reprod Health Care. 2013. PMID: 23387475
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
Bracken H, Dabash R, Tsertsvadze G, Posohova S, Shah M, Hajri S, Mundle S, Chelli H, Zeramdini D, Tsereteli T, Platais I, Winikoff B. Bracken H, et al. Among authors: tsereteli t. Contraception. 2014 Mar;89(3):181-6. doi: 10.1016/j.contraception.2013.10.018. Epub 2013 Nov 12. Contraception. 2014. PMID: 24332431 Free article. Clinical Trial.
14 results